After More than 2 years of first cases of COVID-19 and mass vaccination of people, the COVID-19 remains a global problem in terms of time to time resurge of the disease and problems caused by the outbreak. By the introduction of the vaccines in January 2021, countries started mass vaccinations to reach a desirable population wide immunity. Many of the vaccines were approved in emergency situations to fasten the control of Covid-19 and their safety is still being studied. The COVID-19 pandemic has highlighted the significant health system weaknesses and vulnerabilities specially regarding Immunization plan. It is evident that the COVID-19 pandemic has also caused disruptions in the routine immunizations resulting in the resurgence of vaccine-preventable diseases.
On the other hand, The Vaccine-preventable diseases and immunization programme entered a new decade with the “Immunization Agenda 2030 - A Global Strategy to Leave No One Behind” (IA 2030) addressing key challenges in immunization for the coming years. So, revising the immunization road map to align it with IA 2030 and strengthening the national immunization program is needed. To increase vaccine coverage, and to ensure maintaining coverage of Covid-19 and other EPI vaccines WHO is planning to support National Programme of Immunization in: 1. Conduct a comprehensive assessment of the strengths and weaknesses of an immunization programme at national, subnational, and service-delivery levels, through An EPI Review. 2. Develop New Vaccines Introduction Plans and finalizing proposal to GAVI for support on inclusion of Rotavirus and Pneumococcal Vaccine (PCV) in the National EPI routine This consultancy is to support EPI program in monitoring, analysis, and documentation of the above activities
Skills / Technical skills and knowledge: